1. Advancing Assessment, Analysis, and Reporting of Safety and Tolerability in Cancer Trials. (28th August 2020) Authors: Kluetz, Paul G; King-Kallimanis, Bellinda L; Suzman, Daniel; Chang, Elaine; Brave, Michael M; Weinstock, Chana; Bhatnagar, Vishal; Beaver, Julia A; Chuk, Meredith K Journal: Journal of the National Cancer Institute Issue: Volume 113:Number 5(2021) Page Start: 507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Demystifying the estimand framework: a case study using patient-reported outcomes in oncology. Issue 10 (October 2020) Authors: Fiero, Mallorie H; Pe, Madeline; Weinstock, Chana; King-Kallimanis, Bellinda L; Komo, Scott; Klepin, Heidi D; Gray, Stacy W; Bottomley, Andrew; Kluetz, Paul G; Sridhara, Rajeshwari Journal: Lancet oncology Issue: Volume 21:Issue 10(2020) Page Start: e488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Exploration of baseline patient-reported side effect bother from cancer therapy. (June 2020) Authors: Roydhouse, Jessica K; King-Kallimanis, Bellinda L; Roy, Pourab; Weinstock, Chana; Krol, Danielle; Daniels, Selena R; Suzman, Daniel L; Beaver, Julia A; Kluetz, Paul G Journal: Clinical trials Issue: Volume 17:Number 3(2020) Page Start: 332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Patient reported outcomes in anti-PD-1/PD-L1 inhibitor immunotherapy registration trials: FDA analysis of data submitted and future directions. (June 2019) Authors: King-Kallimanis, Bellinda L; Howie, Lynn J; Roydhouse, Jessica K; Singh, Harpreet; Theoret, Marc R; Blumenthal, Gideon M; Kluetz, Paul G Journal: Clinical trials Issue: Volume 16:Number 3(2019) Page Start: 322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Patient-Reported Outcomes in Pediatric Cancer Registration Trials: A US Food and Drug Administration Perspective. (30th April 2021) Authors: Murugappan, Meena N; King-Kallimanis, Bellinda L; Reaman, Gregory H; Bhatnagar, Vishal; Horodniceanu, Erica G; Bouchkouj, Najat; Kluetz, Paul G Journal: Journal of the National Cancer Institute Issue: Volume 114:Number 1(2022) Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working group. Issue 2 (February 2023) Authors: Piccinin, Claire; Basch, Ethan; Bhatnagar, Vishal; Calvert, Melanie; Campbell, Alicyn; Cella, David; Cleeland, Charles S; Coens, Corneel; Darlington, Anne-Sophie; Dueck, Amylou C; Groenvold, Mogens; Herold, Ralf; King-Kallimanis, Bellinda L; Kluetz, Paul G; Kuliś, Dagmara; O'Connor, Daniel; Olive... Journal: Lancet oncology Issue: Volume 24:Issue 2(2023) Page Start: e86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Time to deterioration of symptoms or function using patient-reported outcomes in cancer trials. Issue 5 (May 2022) Authors: Fiero, Mallorie H; Roydhouse, Jessica K; Bhatnagar, Vishal; Chen, Ting-Yu; King-Kallimanis, Bellinda L; Tang, Shenghui; Kluetz, Paul G Journal: Lancet oncology Issue: Volume 23:Issue 5(2022) Page Start: e229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Timing is everything: The importance of patient-reported outcome assessment frequency when characterizing symptomatic adverse events. (June 2022) Authors: King-Kallimanis, Bellinda L; Bhatnagar, Vishal; Horodniceanu, Erica G; Chen, Ting-Yu; Kluetz, Paul G Journal: Clinical trials Issue: Volume 19:Number 3(2022) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. US Food and Drug Administration review of statistical analysis of patient-reported outcomes in lung cancer clinical trials approved between January, 2008, and December, 2017. Issue 10 (October 2019) Authors: Fiero, Mallorie H; Roydhouse, Jessica K; Vallejo, Jonathon; King-Kallimanis, Bellinda L; Kluetz, Paul G; Sridhara, Rajeshwari Journal: Lancet oncology Issue: Volume 20:Issue 10(2019) Page Start: e582 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗